Entera Presents Markedly Enhanced Anabolic Effects of EB613 (First-in-Class Oral PTH(1-34) Tablet) in Postmenopausal Women with Osteoporosis at High Risk of Fracture and Showcases Phase 3 Design at AS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| Entrx Corporation (NASDAQ: ENTX) | Delayed: 2.98 -0.07 (2.3%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.05 | 52 Week High | $0.30 | |||
| Open | $3.01 | 52 Week Low | $0.10 | |||
| Day High | $3.03 | P/E | N/A | |||
| Day Low | $2.90 | EPS | $0.00 | |||
| Volume | 382,681 | |||||
